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Abstract
This chapter presents a review of what is known about the natural history of 
the Ebolaviruses in Central and West Africa as well as in the Philippines. All the 
previous hypotheses on the natural cycle of Ebolavirus are revisited. Also, the main 
factors driving the virus natural cycle are summarized for the different ecosystems 
where the Ebolavirus is known to have emerged, including the virus species, the 
date of emergence, the seasonality, the environmental features, as well as the 
potential risk and associated factors of emergence. The proposed hypothesis of 
the Ebolavirus natural cycle prevails an inter-species spillover involving several 
vertebrate hosts, as well as biotic and abiotic changing environmental factors 
among other original features of a complex natural cycle. It is also compared with 
other virus having such type of cycle involving chiropteran as potential reservoir 
and vector and presenting such original inter-outbreak epidemiological silences. 
Ultimately, these observations and hypotheses on Ebolavirus natural cycles give 
some insight into the potential drivers of virus emergence, host co-evolution, and a 
spatiotemporal dimension of risk leading to identify high risk areas for preventing 
emerging events and be prepared for an early response.
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1. Introduction
It has been several decades since an unknown fever dramatically emerged, 
close to the Ebola river, a small tributary of the great Ubangi river in the heart 
of the Congolese tropical forest of Africa. Since that time, even though the virus 
responsible for this new hemorrhagic fever has been identified and character-
ized, the natural history of the eponymic Ebolavirus remains largely unknown. 
The cradle of the virus remains enigmatic and the emergence of the Ebola fever 
unsolved. Indeed, the arcane of Ebolavirus natural history is still hypothesized, 
thanks to an elusive virus that always risen where it was not expected, violent and 
devastating, and surprising local populations and health systems, as well as the 
international scientific community. This Ebolavirus eco-epidemiology remains 
complex while the Ebola fever (alias Ebolavirus Disease) can be considered as 
an exemplary disease that can be eventually comprehended only with a trans-
disciplinary approach that has recently been promoted as a One Health concept. 
Indeed, it is only when we take into account all disease and virus drivers, including 
Emerging Challenges in Filovirus Infections
2
biotic and abiotic factors of the natural and human environments, that some 
mechanisms of the Ebolavirus disease emergence, such as spread and circulation, 
can be ultimately unveiled. For that, we have collected all information available, 
often estimated, from the time and place of the virus emergence long before the 
emerging event was identified as it and the epidemic phase was brought to public 
attention. Moreover, when available we also collect all data on potential natural 
and accidental hosts, weather and environment chorology, among other multiple 
factors potentially involved.
Historically, Ebolavirus emerged in Central Africa in the late 1970s, and has 
re-emerged most recently with the active epidemic (April 2019) in the eastern 
Democratic Republic of Congo (DRC), by encompassing more than 24 epidemic 
events from Central to West Africa, to imported infected monkey from Asia to 
Virginia, and the emerging new Ebola species of the Philippines archipelago [1].
Among the negative sense RNA viruses of the Filoviridae family five genera are 
known, including Cuevavirus, Ebolavirus, Marburgvirus, Thamnovirus. Among the 
Ebolavirus genus, five Ebolavirus (EBOV) species have been identified [2].
Ebolavirus’ (EBOV) first emergence occurred in 1976, as two different EBOV 
species in two different places in sub Saharan Africa. The Zaire Ebolavirus (ZEBOV) 
species and the Sudan Ebolavirus (SUDV) were detected concomitantly, a few 
weeks apart, respectively in the Northeastern Equator province of the Democratic 
Republic of Congo, DRC (alias Zaire), and in the Bahr el Ghazal province of South 
Sudan. On the 26th of August 1976 ZEBOV was isolated from missionaries and local 
villagers of the Yambuku, in the rain forest close to the Ebola river. However, earlier 
in June 1976, the SUDV had broken out among cotton factory workers in Nzara, 
Sudan (now in South Sudan) [3].
Then, in 1989, the Reston Ebolavirus species surprisingly (RESTV) emerged in 
the US (!) and was identified during an outbreak of simian hemorrhagic fever virus 
in crab-eating macaques from Hazleton Laboratories (now Covance) of Reston 
county, Virginia. Such primate specimens were found to be recently imported from 
the Philippines. Then, in 1994 a fourth new species of Ebolavirus was isolated from 
chimpanzee leaving in the Tai Forest of Côte d’Ivoire and named Côte d’Ivoire 
ebolavirus (CIEBOV). Finally, in November 2007, a fifth Ebolavirus species, was 
detected from infected patients in Uganda in the Bundibugyo District and was 
subsequently identified by the eponymic name of Bundibugyo Ebolavirus [4].
Briefly and extraordinarily among the world of the viruses, the filovirus virion 
presents a bacilliform (filamentous) shape, like a Rhabdovirus, but presents unique 
pleomorphic figures with branches and other tortuous shapes. Ebolaviruses have 
also an unusual and variable long length - up to 805 nanometers (only some plant 
virus can compete to this filamentous extensive length). However, the internal 
structure is more classical with a ribonucleoprotein nucleocapsid, a lipid envelope 
and seven nanometers size spikes. The genome is non-segmented, single stranded 
RNA of negative polarity with lengths of about 18.9 kb that code for seven proteins, 
each one having a specific function [5].
Ebolaviruses are known for their high case-fatality rate (CFR) with always 
less than 2/3 of survivors among the identified cases. ZEBOV, the most frequently 
isolated Ebolavirus species during the outbreaks, has the highest CFR, up to 
90% in some instances, with an average of 83% for the past 37 years. The Uganda 
BDBV outbreak had a mortality rate of 34%. RESTV imported to the US did not 
cause disease in exposed human laboratory workers. The scientist performing 
the necropsies on CIEBOV infected chimpanzees got infected and developed a 
Dengue-like fever, fully recovered 6 weeks after the infection while treated in 
Switzerland.
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2. When Ebolavirus raised his head in the heart of darkness
Dates and time make History. Indeed, the various reports on the emergence of 
Ebolavirus in Africa show discrepancies and lack accuracy, for multiple reasons 
(remote event, reports by different person or team, at different time…) but the 
only way to forge the history is to label the events with date, time and the envi-
ronmental factors observed. On July 27, 1976, the first (known) victim to contract 
Ebolavirus was a cotton factory worker from Nzara, Sudan. Then, in Zaire (DRC) 
on September 1, 1976, the first Ebolavirus (Zaire ebolavirus, ZEBOV) victim was 
a teacher who had just returned from a family visit to northern Zaire (6 Jennifer 
Rosenberg Internet). These two events were the very beginning of the boundless 
journey of a deadly Ebolavirus outbreaks.
2.1 The Ebolavirus species emerging events
When the virus becomes epidemic in a human population, it does so weeks or 
months after the emergent event of the virus switching from its silent transmission 
in a natural cycle to a zoonotic/epidemic manifestation, revealed to the local health 
system. Let us see in more detail such emerging events of Ebolavirus species (ICTV, 
2018) as there were reported or sometime interpreted, in time and place.
Sudan ebolavirus (SEBOV) occurred when the first recorded SUDV broke 
out among cotton factory workers in Nzara, South Sudan in June 271,976. This 
was indeed, the first case of Ebolavirus infection recorded and confirmed and 
also reported as potentially exposed to chiropteran. Indeed, at the Nzara Cotton 
Manufacturing Factory this first patient was a cloth room worker where bats 
(mostly Tadarida - mops - trevori) have a large population in the roof space of their 
premises. He died in the Nzara hospital on July 6, 1976. Local animals and insects 
were tested for Ebolavirus without success [6, 7].
Zaire ebolavirus (ZEBOV) was reported in the Mongala district of the 
Democratic Republic of Congo (DRC; alias Zaire) in August 1976, when a 44-year-
old schoolteacher of the Yambuku village, became the first recorded case of 
Ebolavirus infection in DRC. Also, the schoolteacher travel earlier in August 1976 
near the Central African Republic border and along the Ebola River, estimated 
90 km NW from the village [6].
Reston ebolavirus (REBOV) had its first emerging event as an imported infected 
cynomolgus monkey (Macaca fascicularis) in October 1989 imported from a facility 
in the Philippines (Mindanao Island) to Reston, Virginia, USA, where the primate 
got sick and the virus isolated [8]. In the Philippines, in several instances, the virus 
was found to infect pigs, in June and September 2008 ill pigs were confirmed to be 
infested by REBOV (Ecija and Bulacan, Manila island), as well during 2008–2009 
epizootics in the island of Luzon (Philippines) [9].
Cote d’Ivoire ebolavirus (CIEBOV) was isolated for the first time, and as an only 
known appearance, in November 1994, from wild chimpanzees presenting severe 
internal bleeding of the Taï Forest in Côte d’Ivoire, Africa. A researcher became 
infected when practicing a necropsy on one of these primates, he developed a den-
gue syndrome and survived. At that time, many dead chimpanzees were discovered 
and tested positive for Ebolavirus. However, the source of the virus was believed to 
be of infected western red colobus monkeys (Piliocolobus badius) upon which the 
chimpanzees preyed [10].
Bundibugyo ebolavirus (BDBV) was then discovered during an outbreak of 
Ebolavirus in the Bundibugyo District (Bundibugyo and Kikyo townships), on 
August 1st, 2007, in Western Uganda (Towner et al. [11]). BDBV second emerging 
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event was observed in the DRC in August 17, 2012 in Isiro, Pawa and Dungu, 
districts of the Province Orientale [11].
With the exception of REBOV in Philippines and CIEBOV in West Africa, all 
other EBOVs species emerged in the Central African region. Also, all EBOVs are 
known to emerged in the tropical rain forest during the inter-season between dry 
and rainy seasons. Also, REBOV appears to actively circulate in the tropical rain or 
moist deciduous forest of the Philippines [12].
2.2 From Central Africa to West Africa
2.2.1 Concurrent emergences of Ebolaviruses
On several occasions, concurrent emerging events of Ebolavirus have been 
observed. Indeed, such events occurred in places geographically distant, indepen-
dent, and unconnected. The Ebolavirus was isolated and the strains different, even 
they belonged to the same species of Ebolavirus, altogether in favor of a different 
origin from an elusive natural reservoir, thus eliminating the notion of leaping from 
one site to the other. In that matter, the following observations are a paradigm: From 
its inceptive emergence the Ebolavirus was identified in Sudan at the cotton factory 
and a few days later at Yambuku, Zaire. The Ebola Sudan and Ebola Zaire viruses 
emerged concurrently in 1976 in the Congo basin of Central Africa; More than 
20 years later the virus emerged and reemergence from 1994 to 1996 in a different 
places in Gabon, in a successive and timely overlapping events but in unconnected 
areas from where different strains of the same EBOVZ were isolated [13]; More 
recently, during the 2014–2016 dramatic Ebolavirus disease (EVD) emergence of in 
West Africa where the virus emerged in late December 2013 of a 18-month-old boy 
from the small village of Meliandou (Guéckédou district, South-Eastern Guinea) 
believed to have been infected by bats [14], concurrently, in August 2013, the 
Ebolavirus reemerged in the Equator province of DRC - different places and differ-
ent strain of ZEBOV [15].
It is remarkable that most of these emerging events occurred during or close to 
the end of the rainy season which generally stretches from August to October in the 
domain of the Congo basin tropical rain forest.
Altogether, these observations are in favor of environmental factors of emer-
gence favoring, when they occur synchronously in the same place, the spillover 
of the virus from its hidden natural cycle to an accidental and susceptible host. 
Therefore, these plural and concomitant emerging events play against the theory 
of Ebola virus diffusing in oil spot in Central Africa [16]. This original pattern of 
concurrent emergences could explain also the relative stability of the virus strains 
which remain for years in the same environment, and the interepidemic silences 
which require several fundamentals (i.e. concurrent risk factors) to be broken.
2.2.2 An unexpected broader domain of Ebolavirus circulation
The first evidence that showed that Ebola virus had previously circulated in 
areas without any known cases of disease came in 1977, near the Ebola outbreak 
in Tandala, DRC, just 200 miles west of the first known cases in 1976 [17]. Blood 
samples obtained from individuals in areas with no previous symptoms of Ebola 
were found to contain antibodies for Ebolavirus, indicating a previous or ongoing 
infection with that virus. Because subclinical illness is always a possibility with 
viral infections, the presence of these Ebolavirus-specific antibodies could only be 
explained by exposure to the virus, which is somewhat reasonable in an area that is 
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endemic to the disease. But how do we know the true endemic zone of a virus such 
as Ebolavirus?
Endemic zones are primarily based on where disease can most likely be 
expected, and are determined by historical accounts of disease, as well as supple-
mental information such as where animals or insects that might transmit the 
disease are located. With respect to the Ebola virus, outbreaks that occur in Central 
Africa, in or near the Congo River Basin, are expected; outbreaks that take place 
elsewhere are unexpected and can be problematic, as was the case for the 2014–2016 
West African outbreak. And yet, scientists have highlighted the presence of Ebola 
antibodies well outside the endemic zone for disease for decades.
In the early 1980’s, research based at the Pasteur Institute in Bangui, Central 
African Republic, demonstrated for the first time that the population of central 
Africa presented natural antibodies against the Ebolavirus strains of Zaire and 
Sudan [3, 4]. Research also showed for the first time that several mammal spe-
cies had Ebolavirus-reacting antibodies, including rodents, dogs, and others. 
Initially, the scientific community was skeptical of the findings, due to the type of 
antibody tests used, and because the prevalence of these antibodies was unbeliev-
ably dispersed and at a high level of prevalence. However, a 1989 follow-up study 
confirmed methodology and preliminary observations, and expanded the results 
to include similar observations in Cameroon, Chad, Gabon, and Republic of Congo 
(the latter two of these countries would have their first Ebola outbreaks in 1994 
and 2001, respectively) [5]. Moreover, such Ebolavirus antibody prevalence was 
found in West Africa (e.g. Senegal, Chad, Sierra Leone), preceding the catastrophic 
2014–2016 Ebolavirus outbreak [18]. Subsequent studies have determined that 
20–25% of persons living in or near the Congolese rain forest are seropositive for 
Ebola, despite never exhibiting symptoms [19].
Today, Ebola antibody prevalence is widely distributed across the African conti-
nent in the absence of severe clinical presentation and/or outbreak manifestation. A 
1989 study even found Ebola Zaire antibodies among people living in Madagascar, 
an island country that has never had a single known case of Ebola, and which has 
been geographically separated from continental Africa for 100 million years [20].
Risk mapping, including ecological and geographical distribution <10-13 cm/s 
first hour, and extended, highly sensitive and specific environmental and biogeo-
graphical models based on EBOVs susceptible mammalian biogeography in Africa, 
show a robust and precise potential distribution of EBOVs in Africa that clearly over-
lap the African tropical rain forest biome of the Guinea-Congo forests (including the 
Congo basin rain forest, and the Occidental relic of the Congolese rain forest spread-
ing from Guinea to Ghana) and the southern band of the Sudan-Guinea Savanna [21].
Also, as a result of potential Ebolavirus (or Ebolavirus antigen) exposure, 
serological markers have been found in vertebrates outside of Africa. With the 
exception of Philippines, where REBOV is known to circulate in monkeys and 
pigs, thus showing its ability to infect multiple animal species, in several instances 
serological evidence of Ebolavirus exposure has been detected in many vertebrates, 
particularly chiropterans [9]. Definitely, bat populations in Bangladesh and China 
present antibodies against ZEBOV and REBOV proteins [22, 23]. Ultimately, it 
appears that EBOVs are widely distributed throughout Africa, West and Central, 
and Asia. Moreover, risk mapping of filovirus ecologic niches suggests potential 
areas of EBOVs distribution in Southeast Asia [24].
The unexpected detection of REBOV first in Virginia, for the reason we know, 
and then the astonishing discovery of its circulation and natural cycle in the 
Philippines gave a rethinking of the entire family of Ebola viruses previously known 
mainly on the African continent [25].
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From these observation and facts, the potential circulation of EBOVs in its 
natural cycle appears much wider than expected, while the emerging events we can 
witness appears to be only a tip of the iceberg in the wide Congolese tropical rain 
forest.
2.3 From the index case to the epidemic chain, outbreak, and pandemic
The fundamentals of emergence are changing in the heart of the rainforest and 
elsewhere: changing times, when the means of transmission switch from foot to 
motorbike, when knowledge conveyance has switched from paper reporting to the 
internet.
Let us examine the risk of expansion for Ebolavirus. Indeed, the factors of trans-
mission of the virus to man and man to man are essential to take into account in this 
context. Moreover, it is extremely important to note that these factors are subject 
to permanent changes in societies whose trade and means of communication are 
drastically changing as a result of health systems, responses and preparedness for 
epidemics at national and international levels, policies, and the economy.
So, with the experience gained for more than 40 years, the strategies of struggle 
are clearly defined, but the societal changes that are taking place make their appli-
cation difficult and sometimes impossible (e.g., the 2019 outbreak in the DRC, 
where political institutions have prevented an adapted response). Situation and the 
epidemic are perpetuated.
There is also a growing means of communication, both smartphones and motor-
ized transport, to travel more quickly as ever, between the epidemic zone of EVD 
and the family [26].
Thus, during the emergence of the Ebola virus in West Africa, all of this means 
of communication played a fundamental role in the regional spread of the epidemic, 
until it became a pandemic risk when the virus was exported to other countries of 
the African continent and, outside Africa in Europe and North America [27].
3.  A strange iteration of epidemic events with unexplained virus 
disappearance
It is known for several other transmitted viruses that during the inter-epidemic 
silences several factors can be responsible. In general mass herd immunity (natural 
of due to acquired immunization i.e. vaccine) of the permissive hosts force the virus 
in its natural cycle without apparent clinical manifestation in the hosts (e.g. Most 
by the arbovirus classically yellow fever, Dengue, Japanese encephalitis, West Nile, 
Zika etc.).
The Paramyxoviridae and Rhabdoviridae are the two other viral families in the 
order Mononegavirales, genetically closely related to the Filoviridae and having 
chiropteran as reservoir and/or vector [28]. Indeed, it is interesting to note that 
megachiropteran fruit bats are reservoirs of Hendra and Nipah viruses of the 
Paramyxoviridae family [29]. When, Microchiroptera bats are the probable ances-
tors of all rabies virus variants of the Lyssavirus genus in the family Rhabdoviridae 
and infecting presently terrestrial mammals [30]. Both also present this cryptic 
interepidemic silences that has not been yet clearly understood. The Nipah emerged 
one time in Malaysia (1999), thought to have its original cycle in PNG, and 
ultimately reemerged more than 3500 km away in Bangladesh in 2001. From its 
inception, again the Marburgvirus (the closest to EBOVs in the family of Filovirus), 
emerging events from an expected natural foci occurred within the path of time 
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including 4 to 11 years of inter-epidemic silences occurring mostly in distant sites of 
Eastern and South Africa (Uganda, Zimbabwe, Angola, Kenya).
If one were to describe the history of Ebola outbreaks, one could simply con-
struct a timeline, with a point on the line for each outbreak. You could create this 
timeline with a varying number of points, depending on your methodology, but 
regardless of how you built your timeline, there would be spaces between these 
points. This is due to the nature of Ebola; it appears, it disappears, and it appears 
again. To the Ebola virus, these gaps are periods of convalescence. To us, they 
are periods of absence and mystery, and one of these gaps stands out as the most 
mysterious (Figure 1).
The CDC lists five Ebola outbreaks in the late 1970’s. The “first” Ebola outbreak 
took place in 1976, though we now recognize the event as two simultaneous and 
separate outbreaks. Between June and November 1976, 284 cases (151 deaths) of 
Ebola Sudan occurred near what is now Nzara, South Sudan; between September 
and October 1976, 318 cases (280 deaths) of Ebola Zaire occurred near what is now 
Yambuku, Democratic Republic of Congo (DRC). In November 1976, a researcher 
in England that was working with samples from the Nzara outbreak accidentally 
infected himself; CDC lists this accident as the third Ebola outbreak (the indi-
vidual recovered). In June 1977, a child became sick and died from Ebola Zaire 
in Tandala, DRC though there was only one confirmed case, subsequent epide-
miological investigations of the area uncovered several other historical, probable 
cases. Finally, between July and October 1979, 34 cases (22 deaths) of Ebola Sudan 
occurred, unbelievably, in Nzara, Sudan – the same community where the first 
cases of Ebola emerged just 3 years prior. In the span of just 39 months, the terror 
of Ebola had introduced itself to the world five times (638 cases, 454 deaths) and 
then… silence.
Ebola would not reappear for 10 whole years, and even then, the subtype 
was Ebola Reston, which we now know does not affect humans. Though CDC 
lists four Ebola Reston outbreaks between 1989 and 1992, the world would not see 
another case of Ebola virus disease in humans until late-1994, in Gabon. Even then, 
the outbreak (52 cases, 31 deaths) was mischaracterized as yellow fever for several 
months. Perhaps the virus’s long absence from the spotlight had removed it from the 
collective consciousness in 1994, certainly in the presence of those pathogens that 
had been circulating and consuming our attention in the meantime.
This fifteen-year disappearance of Ebola, particularly in light of its frequent 
and severe outbreaks in the late 1970’s, has perplexed researchers for decades. 
Figure 1. 
Timeline of Ebolavirus emergence. Emerging events (bars) red = EBOV; blue = SEBOV; green = BDBV; 
horizontal axis = years 1972–2018; vertical axis = no value. Numbers above brackets = years of silent inter-
emerging event.
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The mystery lay, to some extent, within the lack of complete knowledge of the 
virus reservoir, though scientists are now having their long-held suspicions in 
bats confirmed. It’s hard to detect disease when you cannot pinpoint the source. 
Surveillance and reporting have been another confounding element. How many 
times in that fifteen-year period was an illness misdiagnosed as yellow fever, dengue 
hemorrhagic fever, or some other similar illness, because of lack of knowledge or 
diagnostic capabilities, or simply because there was no health care around? We 
will probably never be able to answer this question. Finally, our perceived zone of 
endemicity at the time was limited to northern DRC and southern Sudan. Was the 
virus appearing elsewhere, unbeknownst to us? We certainly were not expecting it 
to emerge in Gabon in 1994, and Uganda in 2000, and West Africa in 2014 [31].
Scientists today continue to be perplexed by the emergence of the virus. What 
brings Ebola out from its hiding place? Is its emergence/re-emergence tied to cli-
mate change? globalization? the changing interface between humans and wildlife? 
If it has to do with any of these increasingly significant factors, how do they explain 
the fifteen-year disappearance?
These days, the virus comes and goes with some predictability—since 2000, out-
breaks have approached a near-annual incidence, sometimes skipping a year, some-
times lasting more than a year. The periods between outbreaks are growing shorter. Is 
this because our capability to detect Ebola outbreaks is improving, or is the virus able 
to infect humans more frequently? One thing is for sure: the world knows that when 
one outbreak ends, another will eventually follow, and we need not wait 15 years.
4. Toward the discovery of the natural cycle of the Ebolaviruses
4.1 The discovery of a putative natural reservoir of Ebolavirus
Since the ZEBOV and SEBOV emergence, extended field studies have been 
conducted to discover the reservoir of EBOVs [32] including the 1976 first recorded 
DRC outbreaks and Sudan, the 1979 outbreak in DRC in 1979 and 1995 following 
the Kikwit outbreak, the same year in the Tai Forest and in 1999 in the Central 
African Republic [33–38] . A total of more than 7000 vertebrates and 30,000 
invertebrates were sampled and tested for the presence of EBOVs. Limited finding 
was inconclusive for an potential EBOVs reservoir status among all these animals. 
Moreover, while several animal species (Bats, birds, reptiles, mollusks, arthropods, 
and plants) were experimentally infected with ZEBOV, only two fruit bat species 
(Epomophorus spp. and Tadarida spp.) developed a subclinical transient viremia 
[39]. If these results were not confirmed in the natural settings, they indicated the 
potential for chiropteran to be natural for EBOVs [40].
Also, historically, the first documented case of EVD in Sudan in 1976, the index 
case was located (by the World Health Organization) in a cotton factory far from 
the forest block, where the only wild significantly abundant species was an insec-
tivorous bat species [21].
Since the discovery of EBOV in 1976, more than half of the epidemic outbreaks 
caused by EBOVs have broken down between Gabon and the DRC. Following the 
successive EBOV outbreaks in Gabon from 1995 to 2001 affecting several animal 
species non-human primates, and wild ungulates and responsible of the dramatic 
decline of great apes (gorilla and chimpanzee) populations in the region (Leroy 
et al. [16]), researchers engaged several missions of captures of wild animals in the 
forest areas affected by the recent past epidemics. Also, 1030 animals were captured 
and analyzed, only three species of fruit bats were found infected with the ZEBOV 
by PCR including: Hypsignathus monstrosus; Epomops franqueti; and Myonycteris 
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torquata. Moreover, antibody reacting anti-Ebola were detected in these species as 
well as for the genus Myonycteris spp. leading ultimately to design Chiropteran as a 
potential reservoir of EBOVs [41].
Since then, many studies have converged in favor of the role of chiropters in 
maintaining EBOV in the wild (Caron et al. [42], Leendertz). In addition, a recent 
study of bats in Sierra Leone showed the association of an EBOV like with several 
species of bats (Mops condylurus and Chaerephon pumilus) from the Molossus family 
[43]. Moreover, a potential direct exposure to Ebola infected fruit bats was also 
reported as a putative index case of large epidemics [44, 45]. Moreover, further 
studies reported on direct infection of natural hosts (primates) by EBOV infected 
bats as highly plausible, given that bats, especially fruit bats, are frequently hunted 
and consumed as bushmeat by human when Cercopithecus species hunt roosting bats 
for consumption [46] also preying on bats has been reported in Cercopithecus asca-
nius and C. mitis (East Africa) as well as bonobos (DRC) [47]. It is also possible that 
different modes of exposure to Ebola virus could lead to different antibody profiles, 
that is, contaminated fruit vs. contact with infected bats during hunting [44, 47, 48].
Altogether, several fruit bats (Epomophorus wahlbergi) and insectivorous bats 
(Chaerephon pumilus, Mops condylurus) experimentally survive to EBOV infections 
[39], EBOV RNA and/or anti EBOV reacting antibodies were detected also in several 
other fruit bat species (Epomops franqueti, Hypsignathus monstrosus, Myonycteris tor-
quata, Eidolon helvum, Epomophorus gambianus, Micropteropus pusillus, Mops condylu-
rus, Rousettus aegyptiacus, Rousettus leschenaultia) giving more insight of the potential 
for chiropteran to be a potential host or reservoir host of EBOVs [22, 49, 50].
Interestingly, REBOV was also found associated with the bats in its natural 
habitat of the Philippines [51]. Also, again in this same Filoviridae family, Marburg 
viruses in Africa are clearly associated with bats [32, 52] as well as the Cueva virus 
in Europe [53]. While REBOV has been find associated with fruit bats, Roussetus 
spp. (Pteropodid family), each filovirus genus is associated with a specific chirop-
teran group including: Marburgvirus with a specific fruit bat, Roussetus aegyptiacus 
(Pteropodid family); and Cuevavirus with insectivorous bat, Miniopterus schreibersii 
(Miniopterid family); except for Thamnovirus isolated form fresh water fish.
Moreover, several virus groups are known to hold bat-borne viruses including 
the coronaviruses, hantaviruses, lyssaviruses, lassa virus, Henipavirus, filovirus 
which are among the most severe of the emerging viruses [54, 55].
Conclusively, this was the first evidence of chiropteran as a potential reservoir 
and/or vector of EBOV, while several wild animals, in particular great apes were 
find highly sensitive to EBOV infection. Also, if several species of chiropteran have 
been identified as a potential virus reservoir,
4.2 The most complete figure of a putative Ebolavirus natural cycle in the central 
African raining forest
From all above observations, records and historical events of EBOVs emerging 
events, several fundamentals of emergence have been identified as well putative time 
and space of such events where, that is when the virus jump from the cryptic natural 
cycle of the reservoir-vector to manifest itself clearly as an open index case of infec-
tion in a susceptible host and the potential opening epizootic or epidemic chain.
4.2.1 The actors
Again, from the literature numerous vertebrates appears to be permissive to 
infection by EBOVs, however, due to their ethology, including environmental hab-
its, societal structure, density and their ability of intra and interspecies to mingle. 
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Altogether primates appear highly susceptible to EBOVs infection including non-
human primate apes, gorilla and chimpanzee, but also cercopithecids (e.g. colobus) 
but also small wild ungulates (e.g. forest duikers) and eventually domestic animals 
(e.g. dogs) [32, 56–58].
One can summarize that EBOVs natural hosts belongs to chiropteran as a 
potential host reservoir represented mostly by Pteropodidae in Africa (REBOV and 
Roussetus; Bombali virus and Molossidae), and as secondary natural or accidental 
wild and domestic hosts including several other mammals: primates (Colobus, 
Cercopithecus), non-human primates (Gorilla, chimpanzee), wild ungulates (dui-
kers) and, human primates. Also this needs to be taken into account with respect 
to other permissive species to EBOVs, indeed, as an example, if Roussetus spp. was 
shown to carry EBOVs reacting antibodies more recently R. aegyptiacus bats were 
demonstrated to unlikely able to maintain and perpetuate EBOV in nature while the 
natural transmission of filovirus in R. aegyptiacus, resulting viral replication and 
shedding are unknown [59].
4.2.2 The stages
The African Rain forest of the Congolese basin appears to be the epicenter of 
EBOVs emerging events. More than 80% of the emerging events of EBOVs occurred 
in the Tropical zone under the influence of the (Intertropical converging zone, 
ITCZ) from five degree North to 5 degrees south and oscillating as much as 40 to 
45° of latitude north or south of the equator based on the pattern of land and ocean 
beneath it [28] (Figure 2).
Temperature and precipitation data for Africa (average data computed from 
1960 to 1990, 300 m resolution [HIJ 05]) were integrated with the distribution map 
of the emergent events of the Ebola virus and the values  calculated for each of the 
emergence points [60].
On all emergence points, the temperature at the time of emergence is not signifi-
cantly different from the average annual temperature over 30 years. The difference 
in temperature between the moment of emergence and the average temperature (of 
30 years monthly average) of the hottest month does not show any difference either. 
Emergence would not be directly related to temperature.
When we compare Ebolavirus emerging events time and the rainfall, there is 
strict quantitative correlation between rainfall and emergence: Most of the emer-
gent events (93.8%) occurred during the rainy season (Figure 2). For precipitation 
values, there is a slightly statistically significant (p = 0.02) positive difference 
between the average precipitation of the month of emergence and the average of 
the monthly average precipitation (over 30 years), indicating that precipitations 
are higher when emergences occur. There is an even more statistically significant 
(p = 0.003) positive difference when considering precipitation of the month pre-
ceding the emergence. Emergence is therefore likely to be associated with rainfall 
intensity and the rainy season. 10/32 emergences occur at the beginning of the rainy 
season, 9/32 in the middle, and 11/32 at the end. Only 2/32 emergences occurred in 
the dry season.
When referring to land use (Figure 3) the temperature at the 6 emergence 
points in “Cropland” is highly significantly less (p = 0.005) than 15% (21.6°C) at 
temperature (24.4°C) to the 9 points in “Tree cover, broadleaved, evergreen, closed 
to open”, however the average temperature of the Cropland (21.6°) is to a degree 
less, significantly lower (p = 0.01) than that of the “Tree cover” (24.5°C).
Ultimately, taking into account these environmental factors, when we look 
for an association between the emergent events of the Ebola virus and the 
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Figure 3. 
Environmental factors surrounding Ebolavirus emerging event: Land use and places of Ebola virus emergence 
in Africa from 1976 to 2014. Land use from ESA 2015, 300 m resolution; red circle = putative place of the Ebola 
virus emergence (index case). Estimated Ebola emergence places are superimposed on the land use layer. The 
identification of the land use types were 32 points (red circle) representing the putative places of Ebolavirus 
emergence are superimposed and are distributed as follows: (1) cropland: 6, (2) herbaceous cover: 5, (3) 
cropland mosaic: 5 (> 50% natural vegetation vs. <50% tree, shrub, herbaceous cover), (4) tree cover with: (a) 
15% of broadleaved, evergreen, closed to open: 9, (b) 15–40% of broadleaved, deciduous, open: 2, (5) flooded, 
fresh or brackish water: 1, (6) urban areas: 3, and (7) water bodies: 1. The limitations of this interpretation 
are linked to the accuracy of the location of Ebolavirus emergence sites ( from literature and reports) and,  
to the evolution of vegetation cover over the past decades since the first emergence of the Ebolavirus occurred  
in Africa.
Figure 2. 
Emerging events of Ebolavirus and climate since the Ebola fever inception in Africa. Left = annual rainfall; 
right = annual temperature. To illustrate the association temperature/rainfall and emergence, the month of 
May was chosen because it is at this time of the year that we observe the most emergent events of the Ebola 
virus. Temperature and rainfall are expressed as an annual average for the period under consideration. 
The precise location of 32 Ebola emergent events are here integrated into the global climatic map of Africa. 
Only 30-year average values per month of rainfall are available for the study period (ref.: WorldClim world 
databases) as well for the average monthly temperature.
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characteristics of the places of these emergences (i.e. land use, temperature, 
rainfall) it turns out that the emergences are always in the zone of heavy rainfall, 
but nevertheless do not follow the moving of the rainy season. Moreover, these 
emergences remain always and remarkably close enough to the Equator, therefore 
in the equatorial forest area with a high hygrometry, and a moderate annual tem-
perature. However, the temperature at the time of emergence is not significantly 
different from the average annual temperature (at the points of emergence) which 
does not allow to distinguish seasonal effect in the emergence-temperature rela-
tionship. Conclusively, we did not identify a seasonality associated with the time 
of emergence, however the emerging events occur in specific geographic zone 
characterized by several environmental factors. Finally, the emergence zones are in 
areas of Land Use with specific temperatures not related to seasonality. Ultimately, 
it is also remarkable that all these emerging events occurred in an area with a highly 
potential presence of apes, virus-sensitive hosts.
4.2.3  Fundamentals and domains of emergence: a theory for a natural cycle of 
EBOVs in Africa
Also, the EBOVs species are closely genetically related, their seems to occur 
by foci in nature. The host appears to be the same, natural or accidental, and the 
transmission done by direct contact with infected hosts or its biological products 
[50, 61]. Altogether, in the early 2000s, before the identification of chiropteran as 
a potential host-reservoir of the EBOVs, a hypothetic natural cycle was described 
empirically based on seasonal environmental climatic factors [55]. Then, taking 
into account bats as a potential reservoir-host, the question of virus transmission 
was central to consider while environmental factors appears to play a major role 
to the host and their natural cycle (Chiropteran physiology) (climate/fructifica-
tion, chorology, bats physiology). Several factors of emergence were then listed 
including: Chronic infection, infected organs, virus shedding, close encounters 
between reservoir and susceptible hosts, food and water resource, seasonality, 
chorology (i.e. causal effect between geographical phenomena – season) in the 
tropical rain forest and the spatial distribution of chiropteran (i.e. index site of 
Ebola emerging events).
Epidemiological field surveys indicate that mass mortalities of apes and monkey 
species due to Ebola virus often appear at the end of the dry season, a period when 
food resources are scarce. Restricted access to a limited number of fruit-bearing 
trees can lead to spatiotemporal clustering of diverse species of frugivorous ani-
mals, such as bats, nonhuman primates, and other terrestrial species foraging on 
fallen partially eaten (by bats) fruits. These aggregates of wild animal species favor 
the contact between infected and susceptible individuals and promote virus trans-
mission. The dry season aggregation of reservoir host species involved in natural 
maintenance cycles, augmented by incidentally infected secondary hosts serving 
as sources for intra- and interspecific transmission chains independent of repeated 
spillover from the reservoir host, provides an ecological setting for amplifying 
enzootic transmission of Ebola virus when a vertebrate hosts are concentrated 
around a scarce number of water sources [62].
In addition to this dietary impoverishment, there are behavioral and physiologi-
cal events occurring among bats during the tropical dry favor the contact frequency 
and intimacy between bats, which can promote transmission of Ebola virus to oth-
ers and increase R0. As an example, megachiropteran fruit bats breeding activities 
and intraspecific competitions between males and grouped kidding of females favor 
the contact between individuals. Moreover, pregnancy can involve physiological 
changes among female bats that alter immune functions and eventually favor virus 
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shedding. Parturition among the African megachiropteran bats occurs throughout 
the year, although seasonal peaks provide birthing fluids, blood, and placental 
tissues, potentially Ebolavirus infected, falling on the ground as a medium highly 
Figure 4. 
(A) Understanding Ebolavirus enzootic and epidemics. Red arrows = cycles of transmission; dashed square = a 
putative natural cycle of Ebolavirus in Central Africa (see B). Fruit bats are considered to be a putative reservoir 
of Ebola virus in Central Africa after 2004; In 2009, several non-human primate epizootic are reported; 1976 
was the first emerging events and subsequent epidemic chains in remote area of the rain forest and close by; 2012 
showed a dramatic spread of the virus associated with motorized transportation and ground network; In 2014 
urban epidemics are reported as well as a pandemic risk and become an international public health emergency. 
(B) Putative natural cycle of Ebolavirus in Central Africa. Red arrow indicates Ebolavirus transmission. 
Numbered red circle of transmission: (1) sylvatic inter- and intra-species transmission; (2) chiropteran 
migration; (3) chiropter to primate (close contact of dejection); (4) primate inter species (Cercopithecus/
chimpanzee); (5) primate to primate (non-human primates); (6) non-human primate epizootic (gorillas); (7) 
chiropter to duikers; and (8) consumption of chiropteran infected food by shrew or wild pig.
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attractive and readily available to scavenging terrestrial mammals [50, 56, 63] 
(Figure 4A and B).
5. If we had to conclude
Based on historical data and observations, the presented hypothesis of the natu-
ral cycle of Ebolavirus emergence prevail an inter-species spillover as the complex 
natural cycle involving several hosts (reservoir, vector, amplifier), as well as biotic 
and abiotic factors in a changing environment among other original features.
Although the natural cycle of EBOVs remains in the darkness of the rain forest, 
strong findings and comparative analysis of close parents of the filovirus throw 
some light to a potential natural cycle of EBOVs in Africa. EBOVs clearly appear 
linked to chiropteran and dependent for merging events in the environmental 
factors. Indeed, it appears that filoviridae are often associated with chiropteran 
while the emergence of the virus strains occurs as a sparse focus with a silent period 
of cryptic virus circulation. When virus transmission, i.e. spillover, from a hidden 
natural cycle, to accidental hosts occurs, it happened in a specific time-frame often 
linked to the season.
One can retain is that the EBOVs complex natural cycle is yet not on entirely 
elucidated and certainly dependent on environmental factors – associated with a 
specific environment of the chiropteran species incriminated (i.e. Different terri-
tories, different cycle) - leading to multiple, sometime concurrent, temporally and 
timely emergence in focus.
Although, other hypothesis has been suggested elsewhere including the Ebola 
virus Disease as an arthropod borne disease among others [42], there is important 
fundamental matters to consider as well before providing more.
However, beyond these hypotheses, fundamental questions subsist in order to 
go further learn. We can cite in particular the mystery of kin between the Reston 
virus of Asia and the Ebola viruses of Africa, would there not be a missing link in a 
geographic area yet to discover. Do the filovirus exist in the Americas hidden in the 
darkness of the tropical forest? Also, the Ebolavirus seems genetically stable, related 
to particular species of chiropter, was it to think about a co-evolution of the host 
and the virus in this closed environment of the forest of the tropical? Today, with 
the endless epidemic unfolding in the DRC, should we revisit our tools and strategy 
of struggle in an ever-changing world? [64].
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